Roth et al. compared the effectiveness of INT-767 in a diet-induced ob/ob mouse model of NAFLD with FXR agonist obeticholic acid (OCA). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.